Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-02 Sale | 2024-02-05 7:15 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 1,585 | $11.54 | $18,291 | 336,728 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 6:53 pm | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 2,000 | $21.03 | $42,052 | 101,338 (Direct) | View |
| 2021-01-26 Sale | 2021-01-28 4:59 pm | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 2,501 | $18.46 | $46,158 | 96,774 (Direct) | View |
| 2020-06-16 Sale | 2020-06-18 6:03 pm | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 7,123 | $15.19 | $108,188 | 160,784 (Direct) | View |
| 2020-06-02 Sale | 2020-06-04 5:40 pm | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 845 | $9.2061 | $7,779 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 7:15 pm | N/A 2034-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 141,000 | $0 | 336,728 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 8:21 pm | N/A 2034-01-02 | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 100,000 | $0 | 116,313 (Direct) | View |
Ownership | 2024-01-03 8:19 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 0 | $0 | 255,000 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 7:10 pm | N/A 2031-02-23 | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 6:53 pm | N/A 2028-12-11 | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 2,000 | $0 | 101,338 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 6:53 pm | N/A N/A | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 2,000 | $6.98 | 101,338 (Direct) | View |
| 2021-01-26 Exercise | 2021-01-28 4:59 pm | N/A N/A | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 377 | $4.62 | 96,774 (Direct) | View |
| 2021-01-26 Exercise | 2021-01-28 4:59 pm | N/A 2028-06-20 | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 1,500 | $0 | 96,774 (Direct) | View |
| 2021-01-26 Exercise | 2021-01-28 4:59 pm | N/A N/A | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 1,123 | $6.98 | 96,774 (Direct) | View |
| 2020-06-16 Exercise | 2020-06-18 6:03 pm | N/A N/A | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 4,260 | $4.62 | 160,784 (Direct) | View |
| 2020-06-16 Exercise | 2020-06-18 6:03 pm | N/A 2028-06-20 | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 7,123 | $0 | 160,784 (Direct) | View |
| 2020-06-16 Exercise | 2020-06-18 6:03 pm | N/A N/A | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 2,863 | $6.98 | 160,784 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-25 4:03 pm | N/A 2030-02-20 | IDEAYA Biosciences Inc. | IDYA | Lackner Mark SVP, Head of Biology | 40,000 | $0 | 40,000 (Direct) | View |